Surmodics has revealed that it is still recovering after it was hit by a cyberattack in June 2025. In a Form 8-K filed with the US Securities and Exchange Commission (SEC), the maker of the Pounce XL ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Surmodics (NASDAQ:SRDX) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement. Analysts estimate that Surmodics will ...

Surmodics makes coatings for medical devices and manufactures chemicals for diagnostic immunoassay tests. On Wednesday morning, before the markets opened, the healthcare company announced that the FDA ...

Surmodics SRDX is set to give its latest quarterly earnings report on Friday, 2025-08-08. Here's what investors need to know before the announcement. Analysts estimate that Surmodics will report an ...

As proxy fights go, the battle for SurModics Inc. (NASDAQ:SRDX), based in Eden Prairie, is downright tame — for now. Last week, Ramius LLC, the alternative investment firm of Cowen & Co. that recently ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today certain ...

You certainly can’t accuse Bruce Barclay of standing still. Since SurModics Inc. (NASDAQ: SRDX) named Barclay CEO in 2005, Barclay has reorganized the drug company’s business units, purchased land, ...

SurModics (SRDX) is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics.

Surmodics, Inc. SRDX demonstrated strong performance in the last reported quarter. Its loss per share was 51.9% narrower than the market estimate and sales beat the same by 8.3%. The strong ...